The National Audit Office (NAO) has raised a red flag over the Medicines Control Agency's (MCA) failure to produce the Acute Kidney Injury (AKI) Investigation Report during the audit of its 2021-2024 financial statements, saying the omission prevented auditors from verifying whether recommendations from the investigation had been implemented.